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Abstract
Amino acid oxidation is known to affect the structure, activity, and rate of degradation of proteins. Methionine oxidation is
one of the several chemical degradation pathways for recombinant antibodies. In this study, we have identified for the first
time a solvent accessible tryptophan residue (Trp-32) in the complementary-determining region (CDR) of a recombinant
IgG1 antibody susceptible to oxidation under real-time storage and elevated temperature conditions. The degree of light
chain Trp-32 oxidation was found to be higher than the oxidation level of the conserved heavy chain Met-429 and the heavy
chain Met-107 of the recombinant IgG1 antibody HER2, which have already been identified as being solvent accessible and
sensitive to chemical oxidation. In order to reduce the time for simultaneous identification and functional evaluation of
potential methionine and tryptophan oxidation sites, a test system employing tert-butylhydroperoxide (TBHP) and
quantitative LC-MS was developed. The optimized oxidizing conditions allowed us to specifically oxidize the solvent
accessible methionine and tryptophan residues that displayed significant oxidation in the real-time stability and elevated
temperature study. The achieved degree of tryptophan oxidation was adequate to identify the functional consequence of
the tryptophan oxidation by binding studies. In summary, the here presented approach of employing TBHP as oxidizing
reagent combined with quantitative LC-MS and binding studies greatly facilitates the efficient identification and functional
evaluation of methionine and tryptophan oxidation sites in the CDR of recombinant antibodies.
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Introduction
The oxidative degradation of pharmaceutical proteins has been
reviewed by several authors [1,2,3,4]. Amino acid residues that are
particularly susceptible to oxidation include cysteine, methionine,
tryptophan, histidine, and tyrosine, in that order. Since recombi-
nant antibodies do not contain significant amounts of free cysteine,
cysteine oxidation will not be addressed here. Instead, we focus on
the oxidation of methionine (Met) and tryptophan (Trp). Oxida-
tion of Met residues in the constant domains of recombinant
antibodies has been demonstrated to impact the interaction with
the neonatal Fc receptor and binding to the Fcc receptors [5].
Induction of Trp oxidation in the complementary-determining
regions (CDRs) of a monoclonal antibody by photooxidation
resulted in a progressive loss of target binding and biological
activity [6].
Oxidation of Met can be induced by incubation with oxidizing
agents like H2O2 [2,5,7,8] or tert-Butylhydroperoxide (TBHP)
[3,5,6,9,10,11], by ultraviolet light irradiation [6,12], and is also
observed in pharmaceutical antibodies at elevated temperature
conditions [10,12]. Trp residues have been oxidized with oxygen
radicals [13] or with Fe(II)/EDTA/Asc [14], and oxidation of Trp
residues in monoclonal antibodies using ozone and UV irradiation
has been reported recently [6,15]. Significant Trp oxidation in the
parathyroid hormone (PTH) was also reported by Ji et al., who
used 2,29-Azobis(2-amidinopropane) dihydrochloride (AAPH) as
stress condition [2]. To our knowledge, none of the reported
oxidizing agents have ever been used to induce oxidation of
solvent accessible Trp residues in a recombinant antibody. In the
present study, an approach employing TBHP as oxidizing agent
and tryptic peptide mapping combined with quantitative liquid
chromatography-mass spectrometry (LC-MS) for the simultaneous
induction, identification and quantification of Trp oxidation in
recombinant antibodies was developed. The described test system
allowed us to identify a Trp residue in the complementary-
determining region that displayed significant oxidation in a real-
time stability and elevated temperature study.
Results
The selected recombinant IgG1 antibody displayed significant
oxidation of Trp and Met in a real-time stability study. Figure 1
illustrates the LC-UV profiles of the stability sample (9 months at
4uC) and the corresponding reference material (stored at 270uC)
after tryptic cleavage. Significant differences in peak intensities of
the tryptic peptides with retention times of 38 min (LC-fraction 2,
containing heavy chain Met-253) and 54 min (LC-fraction 4,
containing light chain Trp-32) could be observed. No significant
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17708differences in peak intensities were observed for the tryptic
peptides containing light chain Met-4, heavy chain Met-34, heavy
chain Met-83, and heavy chain Met-429 by LC-UV analysis.
Moreover, two low abundant unknown peaks were observed in the
UV trace of the stability sample at the retention time of 35 min
(LC-fraction 1) and 52 min (LC-fraction 3) not observed in the
reference material. Oxidized peptides typically elute several
minutes prior to the parent peptides, as the resulting products
are more hydrophilic. The existence of oxidized Met-253 and Trp-
32 was further suggested by LC-MS analysis results, in which mass
differences of +16 Da (LC fraction 1 versus 2) and +4 Da (LC
fraction 3 versus 4) were observed for the detected peptides
(Figure 1, inset). Sequence determination of the oxidized tryptic
peptides was carried out on-line by low-energy CID. The resulting
MS/MS spectra of peptides containing Trp-32 (summarized in
Figure 2) displayed almost complete sequence information for all
selected precursor ions (Figure 1, inset). Based on the fragment
ions in the MS/MS spectra [16], the tryptic peptide of LC fraction
1 was positively identified as an oxidized variant (Met sulfoxide of
Met-253) of the parent peptide in fraction 2. Analysis of the MS/
MS spectra of the peptide species in LC fraction 3 resulted in the
verification of the Trp-32 derivative kynurenine (Figure 2; medium
panel). In addition, the existence of the Trp-32 derivatives 5-
hydroxytryptophan, or ox-indole alanine (both with the identical
m/z of 708.38
3+) not detected by LC-UV analysis was identified by
LC-MS/MS (Figure 2; lower panel) at a retention time of 48 min
and 51 min (Figure 3; lower panel). The masses of the C-terminal
fragment y series ions, y11 to y16, of the oxidized peptides are 4 and
16 Da higher than that of the parent peptide (Figure 2; upper
panel), respectively. Moreover, the detected fragment ions do not
suggest significant oxidation of Trp-35 (detectable at y8 to y10). For
Met-253 and Trp-32 we did not observe mass signals in the total
ion current chromatogram (TIC) suggesting the presence of Met
sulfone (+32 Da) and N-formyl-kynurenine (+32 Da).
Quantitative differences in peptide abundance of Trp-32
containing peptides were displayed by LC-MS analysis followed
by the preparation of extracted ion chromatograms (Figure 3).
Two peptide species with identical MS/MS spectra were found for
m/z 708.38 of the stability sample. The identity of the peptide
species (5-hydroxytryptophan versus ox-indole alanine) remains to
be elucidated in further studies. The extent of oxidation at each
active site was determined by selected ion current chromatogram
analysis of the oxidized product and its parent peptide using the
quantification software GRAMS/32. The quantitative results of
Met-83, Met-253, and Trp-32 oxidation of the stability sample
and the reference standard are summarized in Table 1. Beside the
significant oxidation at the solvent accessible Met-253 (26%) and
trace amounts of oxidation at the buried Met-83 (1.3%), we found
that all of the Met residues of the stability sample were slightly
oxidized, albeit to different extents (Met-4 (1.4%), Met-34 (2.6%),
and Met-429 (5.0%)). These results are in agreement with previous
studies on the evaluation of IgG1 conserved Met residues (Met-
253 and Met-429) in recombinant antibodies [5,6,7,8,9,10,12,
17,18]. However, beside the oxidation of Trp-32 no additional
light or heavy chain Trp was found to be oxidized at detectable
levels. Next, we analyzed the selected antibody after prolonged
incubation (3 M) at elevated temperature (35uC) conditions.
Again, we found increased levels of Met-253 and Trp-32 when
compared with the reference material (Table 1), albeit to different
extend when compared with the stability sample (9 months at
4uC). Subsequently, we evaluated if the oxidation of Trp-32 can be
demonstrated using chemical agents as a model stress system.
Oxidation of exposed Met residues can be induced by incubation
with oxidizing agents like H2O2 [2,5,7,8] or TBHP [3,5,6,9,
10,11]. For the depiction of method development we focused on
the oxidation degree of Met-253 (most susceptible for oxidation),
Met-83 (no susceptibility to oxidation in previous studies), and
Trp-32.
Figure 1. LC-separation UV-profiles of the real-time stability sample (9 months at 46C) and the corresponding reference material
(RS, stored at 2706C) after tryptic cleavage. The m/z-values of Met-253 and Trp-32 containing tryptic antibody peptides, obtained by LC-ESI-
MS, are listed in the inset along with their corresponding LC fraction number. Peak identification and quantification performed by LC-MS.
Chromatographic conditions are described in the materials and methods.
doi:10.1371/journal.pone.0017708.g001
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H2O2 concentrations for 24 h resulted in increasing oxidation of
Met-253, Met-83, and Trp-32 (Table 1). However, the significant
oxidation of the buried Met-83 indicates degradation of the native
antibody. In addition, significant formation of fragmentation
products were observed by SDS-polyacrylamide gel electrophore-
sis under native conditions (data not shown). Since the structural
integrity of the oxidized antibody is a prerequisite for the
subsequent functional analysis of specific oxidized Met and Trp
residues, the application of H2O2 was not further evaluated for the
induction of Trp oxidation.
The incubation of the selected IgG1 antibody with different
TBHP concentrations for 24 h resulted in increasing oxidation of
Met-253 and Trp-32, respectively (Table 1). In addition, a slight
increase in Met-83 oxidation was also observed at a concentration
of 0.7% TBHP, albeit to a different extend when compared with
the experiments applying H2O2 as oxidizing reagent (Table 1).
The Trp-32 is located in the CDR1 region of the antibody light
chain. Evaluation of antibody target binding activity by SPR-
technology indicated a connection between the increase of Trp-32
oxidation and the loss of target binding activity (Table 1, Figure 4).
However, the incubation of the selected IgG1 antibody with 0.7%
TBHP also resulted in a significant formation of antibody
fragments and aggregates when compared with the control study
(Table 1). To minimize degradation events that might impact the
functional analysis of the Trp-32 oxidation the TBHP concentra-
tion was lowered to 0.05% and the incubation time prolonged to 7
days.
These adaptations resulted in increasing oxidation of Trp-32
but did not alter the oxidation level of the buried Met-83 nor the
Figure 2. Low-energy CID mass spectra and resulting amino acid sequence of the triply protonated quasi molecular ions of the non-
oxidized (upper panel) and oxidized (medium and lower panel) tryptic light chain fragment 25–42 at m/z 703.05, 704.39, and
708.38. The oxidized Trp-32 residue is highlighted in bold-face.
doi:10.1371/journal.pone.0017708.g002
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sample (incubation for 24 h w/o TBHP; Table 1). The formation
of antibody aggregates was reduced when compared with the
0.7% TBHP incubation for 24 h and similar to the real-time
stability study. Moreover, the increase of Trp-32 oxidation lead to
a significant loss of target binding activity (Table 1, Figure 4).
Thus, the achieved degree of Trp oxidation was adequate to
identify the functional consequence of the Trp-32 oxidation. In
this study, the Trp-32 of the selected IgG1 antibody was identified
as being solvent accessible by x-ray crystallographic studies (data
not shown). Thus, the facility of TBHP oxidation is governed by
the solvent accessibility of the Met and Trp residues. Taken
together, we have identified a single Trp residue in the CDR
region of a recombinant IgG1 antibody susceptible to oxidation
under real-time storage conditions and to TBHP oxidation.
Discussion
Several studies have evaluated the oxidation of Met residues in
recombinant antibodies using different TBHP concentrations for
up to 24 h [3,5,6,9,10,11]. However, significant formation of Trp
oxidation has so far not been reported. Wei et al. identified a Trp
residue in the CDR3 of the heavy chain that showed susceptibility
to photooxidation but not for TBHP oxidation [6]. Shen et al.
identified a Met residue (Met-107) in the CDR3 of the
recombinant IgG1 antibody HER2 heavy chain that showed
susceptibility to TBHP oxidation [9]. We analyzed the HER2
antibody after prolonged incubation (3 month) at elevated
temperature conditions (35uC) and with the developed TBHP
approach (0.05% TBHP for 7 days). We found strongly increased
levels of Met-255 and moderately increased levels of Met-107
Figure 3. Extracted ion chromatograms (EIC) of m/z 703.05, 704.39, and 708.38 from the reference material and the stability
sample.
doi:10.1371/journal.pone.0017708.g003
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Comparing the Trp-32 oxidation level of the selected antibody
with the Met-107 oxidation level of HER2, the extend of Trp-32
oxidation is significant. Taken together, the degree of light chain
Trp-32 oxidation was found to be significantly higher than the
oxidation levels of the conserved heavy chain Met-429 and the
heavy chain Met-107 of the recombinant IgG1 antibody HER2,
which have already been identified as being sensitive to chemical
oxidation in previous studies. To review the presence of the Trp-
32 residue in already published IgG1 antibody CDRL1 sequences
a BLAST search using the patented protein database of GenBank
was performed with the peptide sequence ASQGISSWLA-
WYQQK [19]. The database search resulted in the identification
of .500 patented protein entries (with 100% sequence identity)
underlining that Trp-32 is widely spread and of general interest for
antibody development and stability testing.
Oxidation is one of the major chemical degradation pathways
for protein pharmaceuticals. Met in recombinant antibodies drew
the greatest attention in several studies as it is most easily oxidized
beside cysteine. To our knowledge, we have identified for the first
time a solvent accessible Trp residue in the CDR region of a
recombinant IgG1 antibody susceptible to oxidation under real-
time storage and elevated temperature conditions. In order to
reduce the time for simultaneous identification and functional
evaluation of potential Met and Trp oxidation sites in the CDR of
recombinant antibodies, a test system employing TBHP and
quantitative LC-MS was developed. The developed model stress
conditions allowed us to specifically oxidize the solvent accessible
Met and Trp residues that displayed significant oxidation in the
real-time stability and elevated temperature study but did not
result in the oxidation of buried Met and Trp residues. The
preservation of structural integrity was further demonstrated by
SEC analysis where no fragment formation and only a minimal
increase of aggregate formation was verified. Moreover, the
achieved degree of Trp oxidation was adequate to identify the
functional consequence of the Trp-32 oxidation by SPR analysis.
In summary, the results obtained in this study demonstrate the
high potential of employing TBHP combined with quantitative
LC-MS with respect to identification and functional evaluation of
Met and Trp oxidation sites in pharmaceutical research and
development.
Materials and Methods
Preparation of oxidized MAb using tert-Butyl
hydroperoxide or H2O2
To generate oxidized antibody, a recombinant IgG1 antibody
was first diluted into 180 mM sodium chloride, 5 mM sodium
acetate, pH 5.0 to a final concentration of 4 mg/mL. Subse-
quently, TBHP or H2O2 was added to the given percentage (v/v)
and the samples were incubated for 24 h or 7 days at room
temperature.
Table 1. Relative quantification of antibody methionine and tryptophan oxidation (Met-83, Met-253, and Trp-32) by ion current
chromatogram analysis of the oxidized product and its parent peptide using the quantification software GRAMS/32TM (columns 1–
4).
Met-83 (+16 Da) Met-253 (+16 Da) Trp-32 (+4 Da) Trp-32 (+16 Da)
% Fragment %
Monomer %
Aggregat % Target Binding
Reference material
(n=4)
0.2 (60.1) 2.1 (60.1) 0.5 (60.1) 0.6 (60.1) ,0.1
99.3 (60.1)
0.6 (60.1)
100 (610)
Stability sample
(9 M at 4uC)
1.3 25.6 8.3 8.1 0.4
97.7
2.0
n.d.
Stability sample
(3 M at 35uC)
0.3 7.6 1.6 3.1 4.8
94.7
0.6
n.d.
Control
(24 h; n=4)
0.6 (60.3) 2.3 (60.4) 0.5 (60.1) 0.6 (60.2) 0.7 (60.1)
98.7 (60.1)
0.5 (60.1)
100 (610)
0.01% H2O2 (24 h) 1.6 48.3 0.8 1.4 n.d. n.d.
0.1% H2O2 (24 h) 5.8 97.4 2.7 3.7 n.d. n.d.
0.2% H2O2 (24 h) 9.5 99.1 5.2 4.0 n.d. n.d.
0.3% H2O2 (24 h) 86.9 100 11.5 8.3 n.d. n.d.
0.2% TBHP
(24 h; n=2)
0.9 (60.1) 73.2 (60.7) 3.2 (60.1) 5.0 (60.2) 1.5 (60.1)
97.1 (60.1)
1.4 (60.1)
96 (610)
0.7% TBHP
(24 h; n=4)
2.0 (60.6) 83.1 (61.6) 6.3 (60.1) 4.8 (60.5) 4.5 (60.1)
92.5 (60.5)
3.0 (60.4)
92 (611)
Control (7 d; n=4)) 0.3 (60.1) 2.4 (60.4) 0.5 (60.1) 1.0 (60.3) n.d. n.d.
0.05% TBHP
(7 d; n=6)
0.5 (60.2) 67.0 (62.8) 13.3 (61.3) 12.0 (61.9) 0.6 (60.1)
96.8 (60.1)
2.6 (60.1)
68 (613)
Formation of fragments and aggregates was monitored by size-exclusion chromatography (Column 5) and target binding was assessed by SPR-analysis (Column 6).
Data is represented as mean 6 S.D; n.d. not determined.
doi:10.1371/journal.pone.0017708.t001
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For detection and quantification of oxidized amino acids within
the molecule, MAb was digested with trypsin. MAb was first
denatured in 0.4 M Tris-HCl, 8 M Gua-HCl, at pH 8.5 by
diluting 280 mg of oxidized MAb in a total volume of 300 mL. For
reduction, 10 ml of 0.1 g/mL dithiothreitol (DTT) were added and
incubated at 50uC for 1 hour. After alkylation of free cysteines by
adding 0.33 g/mL iodoacetic acid (IAA) and incubation at room
temperature in the dark for 30 min, the buffer was exchanged to
digestion buffer (0.1 M Tris-HCl, pH 7.0) by application onto a
NAP5H-gel filtration column (GE Healthcare, Buckinghamshire,
UK). Subsequently, the NAP5H-eluate (500 mL) was mixed with
10 mL of a solution of 0.25 mg/mL trypsin (Trypsin Proteomics
grade, Roche, Penzberg, Germany) in 10 mM HCl and incubated
at 37uC for 1862 h. The digest was stopped by adding 50 mlo fa
10%-trifluoroacetic acid (TFA)-solution.
Detection of oxidized peptides by liquid-
chromatography mass-spectrometry (LC-MS)
The tryptic peptide mixture was separated by reversed phase-
HPLC on a Jupiter C18 column (5 mm, 300 A ˚, 25061 mm;
Phenomenex, Aschaffenburg, Germany) and the eluate online
analyzed with a Q-TOF 1 electrospray mass spectrometer (Waters,
Manchester, UK). The mobile phases of RP-HPLC consisted of
0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile
(solvent B). The chromatography was carried out using a step
gradient from 0–25% solvent B in 33 min, from 25–40% solvent B
in another 32 min and finally from 40–100% solvent B in 5 min.
All experiments were performed on an Ultimate 3000 HPLC-
system in m-configuration (Dionex Softron GmbH, Germering,
Germany) using a flow rate of 40 mL/min. The UV absorption
was measured at a wavelength of 220 nm. 7 mg digested protein
was applied. HPLC-system and mass spectrometer were connected
by PEEK-capillary tubes. Before entering the mass spectrometer, a
3:1-mixture (v/v) of propionic acid and 2-propanol (TFA-fix) was
added to the eluate to reduce the interference of TFA on the
ionization of the peptides. Data acquisition was controlled by
MassLynx
TM software (Waters Micromass, Eschborn, Germany).
Parameters for MS detection were adjusted according to general
experience available from peptide analyses of recombinant
antibodies.
Data analysis for the quantification of oxidation levels
Peptides of interest were identified manually by searching their
m/z-values within the experimental mass spectrum. For the
Figure 4. Analysis of antibody target binding by surface plasmon resonance. Biacore sensorgrams showing the pH 7.0 target binding
(100 nM) following different TBHP exposures.
doi:10.1371/journal.pone.0017708.g004
Table 2. Relative quantification of HER2 methionine
oxidation (Met-83, Met-107, and Met-255) by ion current
chromatogram analysis of the oxidized product and its parent
peptide using the quantification software GRAMS/32
TM.
Met-83
(+16 Da)
Met-107
(+16 Da)
Met-255
(+16 Da)
Reference material ,0.2 ,0.2 2.3
Stability sample
(3 M at 35uC)
0.6 1.6 6.6
Control (7 d; n=2) ,0.2 1.2 (60.1) 2.5 (60.8)
0.05% TBHP
(7 d; n=3)
,0.2 7.2 (60.4) 72.3 (60.7)
doi:10.1371/journal.pone.0017708.t002
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peptides of interest were generated on the basis of their
monoisotopic mass and detected charge states using GRAMS/
32 software (Thermo Fisher Scientific, Dreieich, Germany).
Relative amounts of non-oxidized and oxidized peptides were
calculated by manual integration of the corresponding peaks.
Identification of oxidized peptides by LC-MS/MS
MS/MS experiments were performed on-line on a LTQ
Orbitrap mass spectrometer (Thermo Fisher Scientific) using the
described chromatographic system. Peptides of interest were
isolated on the basis of their mass and charge state and
fragmentation induced by low-energy CID using helium as
collision gas. The collision energy was adjusted according to
stability and mass of the parent ion. Data acquisition was
controlled by Xcalibur software (Thermo Fisher Scientific) using
a manual acquisition mode. MS/MS-data were analyzed
manually using Xcalibur software for mass detection and data
interpretation.
Size exclusion chromatography (SEC)
Size exclusion HPLC analysis of MAb was carried out using a
TSK-Gel SW-3000 column (7.8630 mm, 5 mm particle size;
Tosoh Bioscience, Amsterdam, Netherlands). An isocratic elution
using 200 mM KH2PO4, 250 mM potassium chloride, pH 7.0 at
0.5 mL/min as solvent was used for chromatographic separation
on an Ultimate3000 HPLC-system equipped with UV detection at
280 nm. 150 mg of native or oxidized MAb was injected for the
chromatographic analysis. SEC analyses were controlled and
evaluated using Chromeleon software (Dionex Softron GmbH,
Germering, Germany). Relative quantification of MAb and its
variants was performed by manual integration of the chromato-
graphic peaks and comparison of the respective areas.
Analysis of target binding by surface plasmon resonance
(SPR)
The interaction between the native or TBHP-treated MAb and
the specific target receptor of MAb were measured by surface
plasmon resonance using a Biacore T100 instrument (GE
Healthcare Bioscience, Uppsala, Sweden). To evaluate MAb
interaction to its specific target, the assay type ‘‘Calibration-free
Concentration analysis’’ (BiaEvaluation Software, GE Healthcare
Bioscience, Uppsala, Sweden) was performed. The extracellular
domain of the receptor was immobilized onto a Biacore CM5-
biosensor chip (GE Healthcare Bioscience, Uppsala, Sweden) via
amine coupling to reach maximum coupling density. The assay
was carried out at room temperature with HBS-P-buffer (GE
Healthcare Bioscience) as running and dilution buffer. 5 nM of
native or oxidized MAb samples were injected at a flow rate of
5 mL/min and 100 mL/min at room temperature, respectively.
Association time was 90 s, dissociation phase took 60 s. Regen-
eration of the chip surface was reached by a short injection of
10 mM Glycine-HCl, pH 2.0. Evaluation of SPR-data was
performed by comparison of the biological active amount of an
untreated sample with TBHP-treated samples. Biological activity
of untreated samples was fixed to 100% and oxidized MAb were
set into relation.
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